A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission.

Abstract:

BACKGROUND:Interleukin-2 (IL-2) has immunomodulatory effects, including stimulating the activity of cytotoxic T cells and natural killer cells, and inducing the generation of lymphokine-activated killer cells. The authors investigated whether IL-2 may improve the duration of complete remission (CR) and survival in acute myelogenous leukemia (AML) patients in first CR. METHODS:Eighteen patients were included after achieving a CR and receiving at least two courses of consolidation chemotherapy. Therapy was comprised of IL-2 4.5 x 10(5) U/m2 daily by continuous infusion (CI) for 12 weeks, plus boluses of 1 x 10(6) U/m2 on Day 8 and weekly thereafter while continuing the CI. No further chemotherapy was given after the administration of IL-2 was started. RESULTS:The median age of the patients was 50 years (range, 18-73 years), and 7 patients (39%) had an antecedent hematologic disorder (AHD). The median CR duration was 12 months, with 6 patients still alive in CR at a median follow-up of 64 months (range, 50-82 months). Long term CR by cytogenetics occurred in 2 of 5 patients with a normal karyotype (CR duration of 68+ months and 72+ months, respectively), 1 of 3 patients with t(8;21) (CR duration of 82+ months), 1 patient with inv(16) (CR duration of 67+ months), none of 2 patients with -5/-7 (1 patient died in CR after 10 months), 1 of 2 patients with abnormalities in chromosome 11 (CR duration of 60+ months), and 1 of 4 patients with miscellaneous abnormalities (CR duration of 74+ months). The median survival was 47 months. To assess the significance of these results, the authors selected two historic controls receiving long term postremission chemotherapy per each IL-2 case. The controls had remained in CR for at least as long as the cases when the latter underwent treatment initiation with IL-2 and were matched for the number of induction courses required to achieve CR, AHD, cytogenetic abnormalities, and age. Six of 18 IL-2 patients (33%) were alive in CR at 3 years compared with 7 of 36 controls (19%) (P = 0.31). Nine IL-2 patients (50%) were alive at 3 years compared with 10 controls (28%) (P = 0.13). CONCLUSIONS:These results suggest that IL-2 is tolerable in AML patients in first CR and should be studied further in future studies as a therapeutic strategy to prolong remission duration.

journal_name

Cancer

journal_title

Cancer

authors

Cortes JE,Kantarjian HM,O'Brien S,Giles F,Keating MJ,Freireich EJ,Estey EH

subject

Has Abstract

pub_date

1999-04-01 00:00:00

pages

1506-13

issue

7

eissn

0008-543X

issn

1097-0142

pii

10.1002/(SICI)1097-0142(19990401)85:7<1506::AID-CN

journal_volume

85

pub_type

临床试验,杂志文章,评审

相关文献

CANCER文献大全
  • Adenocarcinoma of the lung in young patients: the M. D. Anderson experience.

    abstract:BACKGROUND:Surveillance, Epidemiology, and End Results (SEER) data for the years 1973-1992 documented that patients age < 50 years presented with more advanced disease. Because of the increase in the incidence rate of lung adenocarcinoma in the past few decades and the presentation of more advanced disease in young pat...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(20000415)88:8<1837::aid-cn

    authors: Liu NS,Spitz MR,Kemp BL,Cooksley C,Fossella FV,Lee JS,Hong WK,Khuri FR

    更新日期:2000-04-15 00:00:00

  • Primary malignant fibrous histiocytoma of the aorta.

    abstract::A rare case of malignant fibrous histiocytoma of the aorta is reported. Review of the literature revealed that primary tumors of the aorta are exclusively mesenchymal tumors that almost invariably pursue a fatal course. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810801)48:3<840::aid-cncr28204

    authors: Chen KT

    更新日期:1981-08-01 00:00:00

  • Differential response to chemotherapy in metastatic breast cancer in relation to estrogen receptor level. Results of a prospective randomized study.

    abstract::The predictive value of estrogen receptor (ER) level for response to chemotherapy was studied in 182 patients with metastatic breast cancer in a prospective study. Patients were stratified according to ER status and dominant site of disease and randomized to one of three regimens: cyclophosphamide, 5-Fluorouracil, and...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19890701)64:1<6::aid-cncr2820640

    authors: Rosner D,Lane WW,Nemoto T

    更新日期:1989-07-01 00:00:00

  • Anti-human T-cell lymphotrophic virus type I antibody-positive adult T-cell leukemia/lymphoma with no monoclonal proviral DNA. A clinicopathologic and immunologic study.

    abstract::Proviral DNA of adult T-cell leukemia virus (HTLV-I) was examined by the standard Southern blotting method in lymph nodes of 45 patients with anti-HTLV-I antibody (ATLA)-positive adult T-cell leukemia/lymphoma (ATLL). Six of these patients revealed no monoclonal proviral HTLV-I DNA in tumor cells. These six patients s...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19891215)64:12<2515::aid-cncr282

    authors: Yoshida T,Kikuchi M,Ooshima K,Takeshita M,Kimura N,Kozuru M,Satoh H

    更新日期:1989-12-15 00:00:00

  • Fostering coping and nurturing hope when discussing the future with terminally ill cancer patients and their caregivers.

    abstract:BACKGROUND:It is challenging for clinicians to foster coping and allow hope when discussing prognosis and end-of-life (EOL) issues with terminally ill cancer patients and their caregivers. To the authors' knowledge, little research evidence is currently available to guide clinical practice. METHODS:The authors conduct...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21011

    authors: Clayton JM,Butow PN,Arnold RM,Tattersall MH

    更新日期:2005-05-01 00:00:00

  • Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon.

    abstract::Two-hundred-four patients with previously untreated adenocarcinoma of rectum, rectosigmoid, and sigmoid colon were retrospectively evaluated to determine patterns of recurrence following curative resection. Seventy-eight (38%) subsequently developed recurrent disease. Of these, 40% (31/78) presented with local recurre...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810915)48:6<1492::aid-cncr2820

    authors: Rao AR,Kagan AR,Chan PM,Gilbert HA,Nussbaum H,Hintz BL

    更新日期:1981-09-15 00:00:00

  • Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors.

    abstract:BACKGROUND:Intracranial primitive neuroectodermal tumors (PNETs) occur in the supratentorial and infratentorial regions of the brain. Although histologically similar, the natural history of the tumor at each site differs. The study goal was to determine whether there was evidence of a genetic difference between suprate...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990715)86:2<331::aid-cnc

    authors: Russo C,Pellarin M,Tingby O,Bollen AW,Lamborn KR,Mohapatra G,Collins VP,Feuerstein BG

    更新日期:1999-07-15 00:00:00

  • Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue.

    abstract::Glucocorticoid and progesterone receptors, tyrosine aminotransferase, gamma-glutamyltransferase and alpha-fetoprotein levels were determined in human hepatocellular carcinoma (HCC) and adjacent liver tissues. Glucocorticoid receptor was present in seven of ten HCC samples, values ranged from 1.9 to 66.8 fmol/mg protei...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19881115)62:10<2134::aid-cncr282

    authors: P'eng FK,Lui WY,Chang TJ,Kao HL,Wu LH,Liu TY,Chi CW

    更新日期:1988-11-15 00:00:00

  • Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging: preliminary results of a prospective study.

    abstract:BACKGROUND:Recently, a highly sensitive fluorescent imaging technique was developed for the real-time identification of hepatic tumors. The authors applied this procedure for the intraoperative detection of radiographically occult hepatic micrometastases from pancreatic cancer. METHODS:Forty-nine consecutive patients ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26594

    authors: Yokoyama N,Otani T,Hashidate H,Maeda C,Katada T,Sudo N,Manabe S,Ikeno Y,Toyoda A,Katayanagi N

    更新日期:2012-06-01 00:00:00

  • Invasive tumor cells and prognosis in a selected population of patients with glioblastoma multiforme.

    abstract:BACKGROUND:After surgical resection, the residual, invasive glioblastoma (GBM) cells give rise to a recurrent tumor, which, in 96% of patients, arises adjacent to the resection margin. METHODS:In this study, the authors prospectively enrolled 25 patients with GBM who underwent gross total resection followed by adjuvan...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.23624

    authors: Mangiola A,de Bonis P,Maira G,Balducci M,Sica G,Lama G,Lauriola L,Anile C

    更新日期:2008-08-15 00:00:00

  • Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: A report from the Pediatric Oncology East and Mediterranean (POEM) group.

    abstract:BACKGROUND:Childhood cancer is a highly curable disease when timely diagnosis and appropriate therapy are provided. A negative impact of the coronavirus disease 2019 (COVID-19) pandemic on access to care for children with cancer is likely but has not been evaluated. METHODS:A 34-item survey focusing on barriers to ped...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33075

    authors: Saab R,Obeid A,Gachi F,Boudiaf H,Sargsyan L,Al-Saad K,Javakhadze T,Mehrvar A,Abbas SS,Abed Al-Agele YS,Al-Haddad S,Al Ani MH,Al-Sweedan S,Al Kofide A,Jastaniah W,Khalifa N,Bechara E,Baassiri M,Noun P,El-Houdzi J,K

    更新日期:2020-09-15 00:00:00

  • Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program.

    abstract::To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Institute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982, 462 patients with resectable Stage III or IV canc...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19870801)60:3<301::aid-cncr28206

    authors:

    更新日期:1987-08-01 00:00:00

  • Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis.

    abstract:BACKGROUND:Recent advances in the early detection of prostatic adenocarcinoma have stimulated interest in the development of techniques for determining metastatic potential. METHODS:One hundred cases of adenocarcinoma, including 66 biopsy and radical prostatectomy specimens; 20 biopsies alone; and 14 transurethral res...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19931115)72:10<3020::aid-cncr282

    authors: Ross JS,Nazeer T,Church K,Amato C,Figge H,Rifkin MD,Fisher HA

    更新日期:1993-11-15 00:00:00

  • Treatment of children with neurogenic sarcoma. Experience at the Children's Hospital of Philadelphia, 1958-1984.

    abstract::Twenty-four children aged 3 months to 18 years (median, 12 years) were treated for neurogenic sarcoma at the Children's Hospital of Philadelphia Cancer Research Center from 1958 through 1984. Sixteen patients had neurofibromatosis (NF). The tumors arose in an extremity or in the trunk (15 patients), the retroperitoneu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870101)59:1<1::aid-cncr2820590

    authors: Raney B,Schnaufer L,Ziegler M,Chatten J,Littman P,Jarrett P

    更新日期:1987-01-01 00:00:00

  • ESR1 mutations in breast cancer.

    abstract::The acquisition of ligand-independent ESR1 mutations during aromatase inhibitor therapy in metastatic estrogen receptor (ER)-positive breast cancer is a common mechanism of hormonal therapy resistance. Preclinical and clinical studies have demonstrated that ESR1 mutations can preexist in primary tumors and can be enri...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.32345

    authors: Dustin D,Gu G,Fuqua SAW

    更新日期:2019-11-01 00:00:00

  • Prophylactic glutamine protects the intestinal mucosa from radiation injury.

    abstract::Glutamine may be an essential dietary component, especially for the support of intestinal mucosal growth and function. This study evaluated the effects of a glutamine-enriched elemental diet, administered before whole-abdominal radiation on gut glutamine metabolism, mucosal morphometrics, and bacterial translocation. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900701)66:1<62::aid-cncr282066

    authors: Klimberg VS,Souba WW,Dolson DJ,Salloum RM,Hautamaki RD,Plumley DA,Mendenhall WM,Bova FJ,Khan SR,Hackett RL

    更新日期:1990-07-01 00:00:00

  • Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations.

    abstract:BACKGROUND:This study explores whether externalizing religious and spiritual beliefs is associated with advanced-stage colon cancer at initial oncology presentation and whether this association is stronger for blacks than for whites. METHODS:Patients who had newly diagnosed, invasive colon cancer were recruited at 9 s...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.31351

    authors: Polite BN,Cipriano-Steffens TM,Hlubocky FJ,Jean-Pierre P,Cheng Y,Brewer KC,Rauscher GH,Fitchett GA

    更新日期:2018-06-15 00:00:00

  • Analysis of the impact of imatinib mesylate therapy on the prognosis of patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha regimens for early chronic phase.

    abstract:BACKGROUND:The effect on prognosis of adding imatinib mesylate to the treatment of patients with Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML) has not been explored fully. The objective of the current study was to evaluate the benefit of adding imatinib to the treatment sequence of patients w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11665

    authors: Kantarjian H,O'Brien S,Cortes J,Shan J,Giles F,Garcia-Manero G,Verstovsek S,Faderl S,Rios MB,Talpaz M

    更新日期:2003-10-01 00:00:00

  • Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients.

    abstract:BACKGROUND:The behavior of diffuse peritoneal mesotheliomas in women and the possible relation between tumor morphology and outcome are uncertain. Reported survival has ranged from < 1 month to > 14 years, and a previous study found that tumor morphology could not be used reliably for predicting outcome. The authors ex...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10209

    authors: Kerrigan SA,Turnnir RT,Clement PB,Young RH,Churg A

    更新日期:2002-01-15 00:00:00

  • Coexistence of chronic myelogenous leukemia and chronic lymphocytic leukemia.

    abstract::A 55-year-old man is reported who initially developed chronic lymphocytic leukemia. Seven years later, after chemotherapy with chlorambucil, chronic myelogenous leukemia was diagnosed in addition to the chronic lymphocytic leukemia. Four previously reported cases with the same sequence of events are reviewed as well a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(1984)54:4<697::aid-cncr282054041

    authors: Schreiber ZA,Axelrod MR,Abebe LS

    更新日期:1984-08-15 00:00:00

  • Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.

    abstract:BACKGROUND:Patients with human papillomavirus (HPV)-related oropharyngeal cancer (OPC) have improved survival when compared with those with HPV-negative OPC. Unfortunately, the American Joint Committee on Cancer seventh edition (AJCC-7ed) staging system does not account for the prognostic advantage observed with HPV-po...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30512

    authors: Malm IJ,Fan CJ,Yin LX,Li DX,Koch WM,Gourin CG,Pitman KT,Richmon JD,Westra WH,Kang H,Quon H,Eisele DW,Fakhry C

    更新日期:2017-05-15 00:00:00

  • Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.

    abstract:BACKGROUND:Transitional cell carcinoma (TCC) of the bladder displays an unpredictable biologic behavior and the morphologic methods of grading tumor malignancy are often insufficient to predict the clinical outcome of patients with TCC of the bladder. Thus, the new indicator should reliably reflect prognosis. In this s...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19961015)78:8<1762::aid-cn

    authors: Shiina H,Igawa M,Nagami H,Yagi H,Urakami S,Yoneda T,Shirakawa H,Ishibe T,Kawanishi M

    更新日期:1996-10-15 00:00:00

  • Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.

    abstract::In a retrospective analysis of 166 patients with chronic hepatitis B followed for up to 8 years, 22 patients had 29 episodes of elevations in serum alpha-fetoprotein (AFP) levels. Twenty-five episodes were due to a transient exacerbation of the underlying hepatitis and 11 of these episodes were followed by a loss of h...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19891115)64:10<2117::aid-cncr282

    authors: Di Bisceglie AM,Hoofnagle JH

    更新日期:1989-11-15 00:00:00

  • Evaluation of size in prognosis of oral cancer.

    abstract::Greatest surface diameter of a cancer, together with suspicion of regional node metastasis, forms the basis for prognosis through the clinical TNM staging system for many cancers. In oral cancer, however, surface size sometimes fails to correlate, or sometimes inversely correlates, with tumor aggressiveness. To shed l...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860701)58:1<158::aid-cncr28205

    authors: Moore C,Flynn MB,Greenberg RA

    更新日期:1986-07-01 00:00:00

  • Sinusoidal hematolymphoid malignancy ("malignant histiocytosis") presenting as atypical sinusoidal proliferation. A study of nine cases.

    abstract::A number of cases of sinusoidal hematolymphoid malignancy ("malignant histiocytosis") in which early lymph node biopsies have not allowed clear separation from benign histiocytic disorders have been observed. Nine such cases in which only a follow-up lymph node biopsy documented their malignant nature are reported. Se...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19861015)58:8<1681::aid-cncr2820

    authors: Weiss LM,Azzi R,Dorfman RF,Warnke RA

    更新日期:1986-10-15 00:00:00

  • The Save our Sisters Project. A social network strategy for reaching rural black women.

    abstract::Why are older black women screened less for breast cancer? What can be done to narrow the racial gap in mammography screening? These are the questions addressed by the Save Our Sisters (SOS) Project, a pilot demonstration study funded by the National Cancer Institute in a rural county of North Carolina. The target pop...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19930801)72:3+<1071::aid-cncr282

    authors: Eng E

    更新日期:1993-08-01 00:00:00

  • Insulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumors.

    abstract:BACKGROUND:Ewing sarcoma family of tumors (ESFTs) are the second most common bone tumor, that most often affects persons ages 3-40 years. The ESFTs rely on signaling through the insulin-like growth factor-1 receptor (IGF-1R) for growth and transformation. The current studies were performed to determine the levels of IG...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20011201)92:11<2941::aid-cncr100

    authors: Toretsky JA,Steinberg SM,Thakar M,Counts D,Pironis B,Parente C,Eskenazi A,Helman L,Wexler LH

    更新日期:2001-12-01 00:00:00

  • Clonal culture and cytogenetics. Indicators of a variant of chronic myelogenous leukemia.

    abstract::The clonal growth pattern of bone marrow and peripheral blood cells from 16 patients with clinically suspected chronic myelogenous leukemia (CML) was evaluated in the double-layer agar system. Cytogenetic studies were performed on parallel marrow and peripheral blood samples. In four cases a unique growth pattern emer...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841215)54:12<2956::aid-cncr282

    authors: Selvaggi S,Wolman SR,Bornstein S,Edinger F

    更新日期:1984-12-15 00:00:00

  • Renal disease after mitomycin C therapy.

    abstract::Fourteen patients with adenocarcinoma of the gastrointestinal tract and pancreas treated with mitomycin C(MMC) and 5-fluorouracil (5-FU) had renal impairment 6-11 months from the beginning of MMC therapy. Two clinical entities were recognized: an acute fulminating renal failure that was rapidly fatal and a chronic slo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811215)48:12<2583::aid-cncr282

    authors: Hanna WT,Krauss S,Regester RF,Murphy WM

    更新日期:1981-12-15 00:00:00

  • Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.

    abstract::Two studies were performed to evaluate the safety, tolerability, and efficacy of irinotecan (CPT-11) in the treatment of adults with malignant glioma. Patients with progressive or recurrent malignant gliomas were enrolled. In the first study, CPT-11 was administered once every 3 weeks as a 90-minute intravenous infusi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11306

    authors: Cloughesy TF,Filka E,Kuhn J,Nelson G,Kabbinavar F,Friedman H,Miller LL,Elfring GL

    更新日期:2003-05-01 00:00:00